PhoenixBio Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

364.82

444.36

356.10

400.25

398.06

355.12

339.05

Other Operating Income

0.00

Total Operating income

364.82

444.36

356.10

400.25

398.06

355.12

339.05

Raw Material Cost

92.86

90.64

90.83

90.61

72.55

110.67

126.67

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

1.17

1.24

1.16

1.24

1.37

1.27

1.28

Selling and Distribution Expenses

257.78

290.82

283.32

285.91

314.26

298.96

317.06

Other Expenses

-0.12

-0.14

-0.13

Total Expenditure (Excl Depreciation)

350.63

381.46

374.16

376.52

386.81

409.62

443.72

Operating Profit (PBDIT) excl Other Income

14.2

62.9

-18.1

23.700000000000003

11.299999999999999

-54.5

-104.7

Other Income

19.50

20.63

14.93

-1.84

-18.80

30.98

-42.87

Operating Profit (PBDIT)

42.93

92.72

4.88

29.20

1.22

-16.13

-141.35

Interest

1.17

1.24

1.16

1.24

1.37

1.27

1.28

Exceptional Items

0.26

0.00

-275.48

0.00

Gross Profit (PBDT)

271.96

353.72

265.27

309.65

325.51

244.46

212.39

Depreciation

9.24

9.19

8.01

7.31

8.77

7.38

6.20

Profit Before Tax

32.78

82.30

-4.29

20.66

-284.40

-24.79

-148.82

Tax

0.77

1.39

2.59

1.47

13.78

1.22

-0.92

Provisions and contingencies

0.00

Profit After Tax

32.01

80.91

-6.89

19.19

-298.17

-26.01

-147.90

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

32.01

80.91

-6.89

19.19

-298.17

-26.01

-147.90

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

32.01

80.91

-6.89

19.19

-298.17

-26.01

-147.90

Equity Capital

0.00

Face Value

0.0

Reserves

1,552.63

1,516.89

1,381.47

1,373.46

1,365.41

1,671.22

1,685.12

Earnings per share (EPS)

7.87

19.88

-1.69

4.74

-73.61

-6.42

-36.63

Diluted Earnings per share

7.87

19.88

-1.69

4.74

-73.61

-6.42

-36.63

Operating Profit Margin (Excl OI)

3.89%

14.16%

-5.07%

5.93%

2.83%

-15.35%

-30.87%

Gross Profit Margin

11.52%

20.59%

1.04%

6.99%

-69.24%

-4.9%

-42.07%

PAT Margin

8.77%

18.21%

-1.93%

4.8%

-74.91%

-7.32%

-43.62%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -17.91% vs 24.80% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -60.44% vs 1,272.46% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -67.55% vs 813.86% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of PhoenixBio Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

364.82

976.93

-612.11

-62.66%

Other Operating Income

0.00

Total Operating income

364.82

976.93

-612.11

-62.66%

Raw Material Cost

92.86

580.89

-488.03

-84.01%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

1.17

7.37

-6.20

-84.12%

Selling and Distribution Expenses

257.78

205.56

52.22

25.40%

Other Expenses

-0.12

-0.74

0.62

83.78%

Total Expenditure (Excl Depreciation)

350.63

786.45

-435.82

-55.42%

Operating Profit (PBDIT) excl Other Income

14.19

190.48

-176.29

-92.55%

Other Income

19.50

7.19

12.31

171.21%

Operating Profit (PBDIT)

42.93

231.13

-188.20

-81.43%

Interest

1.17

7.37

-6.20

-84.12%

Exceptional Items

0.26

22.13

-21.87

-98.83%

Gross Profit (PBDT)

271.96

396.04

-124.08

-31.33%

Depreciation

9.24

33.46

-24.22

-72.38%

Profit Before Tax

32.78

212.43

-179.65

-84.57%

Tax

0.77

64.27

-63.50

-98.80%

Provisions and contingencies

0.00

Profit After Tax

32.01

148.15

-116.14

-78.39%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

32.01

148.15

-116.14

-78.39%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

32.01

148.15

-116.14

-78.39%

Equity Capital

0.00

Face Value

0.00

Reserves

1,552.63

3,714.53

-2,161.90

-58.20%

Earnings per share (EPS)

7.87

26.45

-18.58

-70.25%

Diluted Earnings per share

7.87

26.45

-18.58

-70.25%

Operating Profit Margin (Excl OI)

3.89%

19.50%

0.00

-15.61%

Gross Profit Margin

11.52%

25.17%

0.00

-13.65%

PAT Margin

8.77%

15.17%

0.00

-6.40%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 36.48 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -17.91% vs 24.80% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -8.36% vs 2.95% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 3.20 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -60.44% vs 1,272.46% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 110.73% vs -2,585.00% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2.34 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -67.55% vs 813.86% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 17.00% vs 255.04% in Mar 2025

Quarterly - Interest

Interest 0.12 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -14.29% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 3.89%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025